What is RevZero?
RevZero, Inc. operates as a specialized contract manufacturer focused on the intersection of precision machining and medical technology. Since its inception in 2007, the company has carved out a significant niche in the production of complex medical hardware, including plates, screws, and spacers tailored for extremities, trauma, and spinal care applications. By utilizing advanced 5-axis milling and maintaining ISO-13485:2007 certification, the firm provides a critical link in the supply chain for medical device OEMs.
The company's owner-operated model allows for a unique blend of technical agility and manufacturing discipline. As an FDA-registered entity, RevZero provides the regulatory assurance and technical expertise necessary to support the development of minimally invasive surgical tools, positioning itself as a high-value partner for firms navigating the complexities of modern medical device production.
How much funding has RevZero raised?
RevZero has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in RevZero
PPP
Public-Private Partnership
What's next for RevZero?
Looking ahead, the recent capital deployment is expected to catalyze further advancements in RevZero's manufacturing capabilities. The firm is likely to prioritize the integration of next-generation machining technologies to meet the increasing demand for intricate, high-tolerance medical components. As the medical device market continues to evolve toward more specialized, minimally invasive solutions, RevZero's focus on precision and regulatory compliance will be central to its long-term growth strategy.
Furthermore, the company is poised to leverage its strengthened financial position to optimize its operational footprint and potentially expand its service offerings within the trauma and spinal care segments. By maintaining its focus on high-quality contract manufacturing, RevZero is set to remain a key player in the medical technology ecosystem, driving innovation through reliable, scalable production processes.
